Cargando…

The Protective Effect of Yi Shen Juan Bi Pill in Arthritic Rats with Castration-Induced Kidney Deficiency

Androgens have been linked to the onset, severity, and progression of rheumatoid arthritis (RA). In traditional Chinese medicine (TCM), the most common pattern in RA is kidney deficiency, which partly corresponds to a low sex hormone state. In this study, TCM kidney deficiency was induced in male Sp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Hongyan, Li, Jian, He, Xiaojuan, Lu, Cheng, Xiao, Cheng, Niu, Xuyan, Zhao, Ning, Ju, Dahong, Lu, Aiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329149/ https://www.ncbi.nlm.nih.gov/pubmed/22550538 http://dx.doi.org/10.1155/2012/102641

Ejemplares similares

Yi Shen Juan Bi Pill Regulates the Bone Immune Microenvironment via the JAK2/STAT3 Signaling Pathway in Vitro
por: Xia, Ya, et al.
Publicado: (2021)

Yi Shen Juan Bi Pill Ameliorates Bone Loss and Destruction Induced by Arthritis Through Modulating the Balance of Cytokines Released by Different Subpopulations of T Cells
por: Zhao, Hongyan, et al.
Publicado: (2018)

Yi Shen Juan Bi Pill alleviates bone destruction in inflammatory arthritis under postmenopausal conditions by regulating ephrinB2 signaling
por: Xu, Huihui, et al.
Publicado: (2022)

Immunomodulatory activity of a Chinese herbal drug Yi Shen Juan Bi in adjuvant arthritis
por: Perera, Pathirage Kamal, et al.
Publicado: (2010)

QiShenYiQi pill improves the reparative myocardial fibrosis by regulating autophagy
por: Lv, Shichao, et al.
Publicado: (2020)

QiShenYiQi pill for myocardial collagen metabolism and apoptosis in rats of autoimmune cardiomyopathy
por: Lv, Shichao, et al.
Publicado: (2022)

Effect and Mechanism of QiShenYiQi Pill on Experimental Autoimmune Myocarditis Rats
por: Lv, Shichao, et al.
Publicado: (2016)

QiShenYiQi Pill Improves Myocardial Hypertrophy Caused by Pressure Overload in Rats
por: Lv, Shichao, et al.
Publicado: (2021)

QiShenYiQi pill attenuates atherosclerosis by promoting regulatory T cells, inhibiting T helper 17 cells and accelerating cholesterol excretion
por: Peng, Li, et al.
Publicado: (2017)

Qi-Shen-Yi-Qi Dripping Pills for the Secondary Prevention of Myocardial Infarction: A Randomised Clinical Trial
por: Shang, Hongcai, et al.
Publicado: (2013)

Effect of QiShenYiQi Pill on Myocardial Collagen Metabolism in Rats with Partial Abdominal Aortic Coarctation
por: Lv, Shichao, et al.
Publicado: (2015)

QiShenYiQi pills, a Chinese patent medicine, increase bioavailability of atorvastatin by inhibiting Mrp2 expression in rats
por: Ding, Congyang, et al.
Publicado: (2022)

Cardioprotection against ischemia/reperfusion injury by QiShenYiQi Pill(®) via ameliorate of multiple mitochondrial dysfunctions
por: Chen, Jing Rui, et al.
Publicado: (2015)

Cardioprotective Effects of QiShenYiQi Dripping Pills on Transverse Aortic Constriction-Induced Heart Failure in Mice
por: Ruan, Guoran, et al.
Publicado: (2018)

QiShenYiQi pill activates autophagy to attenuate reactive myocardial fibrosis via the PI3K/AKT/mTOR pathway
por: Lv, Shichao, et al.
Publicado: (2021)

QiShenYiQi Pills, a Compound Chinese Medicine, Ameliorates Doxorubicin-Induced Myocardial Structure Damage and Cardiac Dysfunction in Rats
por: Tang, Dong-Xin, et al.
Publicado: (2013)

The Contribution of Different Components in QiShenYiQi Pills® to Its Potential to Modulate Energy Metabolism in Protection of Ischemic Myocardial Injury
por: Cui, Yuan-Chen, et al.
Publicado: (2018)

Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities
por: Zhang, Jun, et al.
Publicado: (2022)

Corrigendum: Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities
por: Zhang, Jun, et al.
Publicado: (2022)

QiShenYiQi Pills, a Compound Chinese Medicine, Prevented Cisplatin Induced Acute Kidney Injury via Regulating Mitochondrial Function
por: Zhou, Li, et al.
Publicado: (2017)

QiShenYiQi Pills Attenuates Ischemia/Reperfusion-Induced Cardiac Microvascular Hyperpermeability Implicating Src/Caveolin-1 and RhoA/ROCK/MLC Signaling
por: Pan, Chun-Shui, et al.
Publicado: (2021)

Qi-Shen-Yi-Qi Dripping Pills Promote Angiogenesis of Ischemic Cardiac Microvascular Endothelial Cells by Regulating MicroRNA-223-3p Expression
por: Dai, Guo-Hua, et al.
Publicado: (2016)

Identification of the Active Constituents and Significant Pathways of Shen-qi-Yi-zhu Decoction on Antigastric Cancer: A Network Pharmacology Research and Experimental Validation
por: Zeng, Shuhong, et al.
Publicado: (2021)

QiShenYiQi Attenuates Renal Interstitial Fibrosis by Blocking the Activation of β-Catenin
por: Zhou, Zhanmei, et al.
Publicado: (2016)

QiShenYiQi Pills, a compound in Chinese medicine, protects against pressure overload-induced cardiac hypertrophy through a multi-component and multi-target mode
por: Chen, Yuan-Yuan, et al.
Publicado: (2015)

A Network Pharmacology Approach to Explore the Mechanism of HuangZhi YiShen Capsule for Treatment of Diabetic Kidney Disease
por: Zhou, Xue-Feng, et al.
Publicado: (2021)

Yi Shen An, a Chinese traditional prescription, ameliorates membranous glomerulonephritis induced by cationic bovine serum albumin in rats
por: Zhao, Yun-Li, et al.
Publicado: (2022)

Maturation of Murine Bone Marrow-Derived Dendritic Cells Induced by Radix Glycyrrhizae Polysaccharide
por: Li, Xiaobing, et al.
Publicado: (2012)

Pharmaceutical and pharmacological studies of Shen Ma Yi Zhi granule for prevention of vascular dementia: A review
por: Chang, Su-rui, et al.
Publicado: (2022)

Jian-Pi-Yi-Shen decoction inhibits mitochondria-dependent granulosa cell apoptosis in a rat model of POF
por: Jiang, Xiao-Lin, et al.
Publicado: (2022)

Rheumatoid Arthritis with Deficiency Pattern in Traditional Chinese Medicine Shows Correlation with Cold and Hot Patterns in Gene Expression Profiles
por: Wang, Minzhi, et al.
Publicado: (2013)

Network Pharmacology and Experimental Verification Strategies to Illustrate the Mechanism of Jian-Pi-Yi-Shen Formula in Suppressing Epithelial–Mesenchymal Transition
por: Zhao, Yuan, et al.
Publicado: (2022)

Yi-Shen-Hua-Shi Granule Alleviates Adriamycin-Induced Glomerular Fibrosis by Suppressing the BMP2/Smad Signaling Pathway
por: Tan, Zhuojing, et al.
Publicado: (2022)

Correction for: Jian-Pi-Yi-Shen decoction inhibits mitochondria-dependent granulosa cell apoptosis in a rat model of POF
por: Jiang, Xiao-Lin, et al.
Publicado: (2023)

QiShenYiQi Pill Ameliorates Cardiac Fibrosis After Pressure Overload-Induced Cardiac Hypertrophy by Regulating FHL2 and the Macrophage RP S19/TGF-β1 Signaling Pathway
por: Anwaier, Gulinigaer, et al.
Publicado: (2022)

Jian-Pi-Yi-Shen Formula ameliorates chronic kidney disease: involvement of mitochondrial quality control network
por: Liu, Xinhui, et al.
Publicado: (2018)

Bu-Zhong-Yi-Qi pill alleviate the chemotherapy-related fatigue in 4 T1 murine breast cancer model
por: Ouyang, Mingzi, et al.
Publicado: (2014)

Involvement of Circulating Exosomal MicroRNAs in Jian-Pi-Yi-Shen Formula Protection Against Adenine-Induced Chronic Kidney Disease
por: Liu, Xinhui, et al.
Publicado: (2021)

Effects of Bu Shen Yi Sui Capsule on Th17/Treg cytokines in C57BL/6 mice with experimental autoimmune encephalomyelitis
por: Zheng, Qi, et al.
Publicado: (2015)

Distinct Responses of Gut Microbiota to Jian-Pi-Yi-Shen Decoction Are Associated With Improved Clinical Outcomes in 5/6 Nephrectomized Rats
por: Zheng, Lin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j9fntjblf0kcepl7ob9vdrn4r7